Diagnostic Value of Contrast-Enhanced Ultrasound in Solid Renal Tumors
Abstract
Objective: To analyze the diagnostic value of contrast-enhanced ultrasound in solid renal tumors and improve targeted accuracy. Method: We selected 100 patients who received treatment in our hospital from January 2021 to January 2022 and analyzed their medical records and pathology to study the ultrasound and contrast-enhanced features of solid renal tumors. Result: Among 100 kidney patients, 79 had malignant tumors. There were 53 cases of clear cell renal cell carcinoma (CCRCC), 20 cases of papillary renal cell carcinoma (PRCC), and 6 cases of chromophobe cell renal cell carcinoma (CHRCC). 21 cases were benign lesions: 12 cases of renal angiomyolipoma (AML) and 9 cases of renal eosinophilic adenoma (RO). There is a statistically significant difference in the performance of different pathological types of renal tumors during CEUS perfusion; Circular hyperenhancement has certain specificity in malignant kidney tumors. Conclusion: contrast-enhanced ultrasound has certain clinical value in the diagnosis and differential diagnosis of solid renal tumors.
Keywords
Full Text:
PDFReferences
Li CX, Huang BJ, Lu Q, et al. The value of contrast-enhanced ultrasound in the differential diagnosis of renal eosinophilic adenoma and chromophobe cell carcinoma [J]. Chinese Journal of Ultrasound Imaging, 2020 (08).
Sun P, Huang BJ, Xue LY, et al. The value of contrast-enhanced ultrasound in the differential diagnosis of complex renal cysts and cystic lesions in renal clear cell carcinoma [J]. Chinese Journal of Ultrasound Imaging, 2019 (12).
Shen YQ, Du L, Luo J, Wang WS. The value of contrast-enhanced ultrasound and endoscopic ultrasonography in the clinical staging of bladder cancer [J]. Journal of Clinical Ultrasound Medicine, 2021 (03).
Liu H, Hong H. Study on the correlation between ultrasound contrast-enhanced parameters and Ki-67 protein expression in prostate cancer [J]. Journal of Clinical Ultrasound Medicine, 2020 (05).
DOI: http://dx.doi.org/10.18686/jn.v12i2.265
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Shuliang Nan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.